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Abstract
Diverse and rapidly evolving pathogens cause plant diseases and epidemics that threaten crop
yield and food security around the world. Research over the last 25 years has led to an
increasingly clear conceptual understanding of the molecular components of the plant immune
system. Combined with ever-cheaper DNA-sequencing technology and the rich diversity of germ
plasm manipulated for over a century by plant breeders, we now have the means to begin
development of durable (long-lasting) disease resistance beyond the limits imposed by
conventional breeding and in a manner that will replace costly and unsustainable chemical
controls.
Plants turn sunlight into sugar. Thus, plants are rich sources of nutrients and water that are,
to no one’s surprise, host to diverse microbial communities both above and below the
ground. Microbes are likely to have accompanied the first plants that emigrated from water
to land 400 to 500 hundred million years ago. Many of their descendant contemporary
microbes are adapted to take advantage of the nutrient niches afforded to them by the huge
diversity of plants all over the earth. Plants are protected from infection by a “skin,” a waxy
cuticular layer atop the cell wall. Would-be pathogens breaching this barrier encounter an
active plant immune system that specifically recognizes pathogen and altered-self molecules
generated during infection. Consequent regulation of a network of inducible defenses can
halt pathogen proliferation and signal distal plant organs to become nonspecifically primed
against further infection.
Nevertheless, fungal, oomycete, bacterial, and viral pathogens cause devastating epidemics
that have affected human civilizations since the dawn of agriculture (1). The late blight Irish
potato famine of the 1840s was caused by the oomycete Phytophthora infestans (2); the loss
of the world’s first mass-cultivated banana cultivar Gros Michel in the 1920s to Panama
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disease was caused by the fungus Fusarium oxysporum (3); and the current wheat stem, leaf,
and yellow stripe rust epidemics spreading from East Africa into the Indian subcontinent
caused by rust fungi Puccinia graminis and P. striiformis (4) are all testament to the
recurring impact of plant diseases. Plant pathogens can spread rapidly over great distances,
vectored by water, wind, insects, and humans (http://rusttracker.cimmyt.org/). Despite
various cultural practices, crop protection chemicals, and available disease-resistant crop
varieties, an estimated 15% of global crop production is lost to preharvest plant disease (5).
Plant Breeding and Disease Resistance
Humans have selected for disease-resistant crops throughout the history of agriculture, at
times unwittingly (6). As a practiced science, plant breeding for disease resistance originated
with Sir Rowland Biffen in Cambridge, England, who identified a single recessive gene for
resistance to wheat yellow rust caused by P. striiformis (7). The ensuing century of breeding
in nearly every crop species resulted in deployment of disease resistance (R) genes, many of
which were introduced by introgression from sexually compatible wild relatives. Dominant
or semidominant R genes were easier to breed into existing crop cultivars, as they could be
selected functionally in each generation. We now know that R genes are present in
multigene clusters and can occur as true alleles across naturally variant genetic backgrounds.
The function of each R protein is activated by the product of a specific pathogen virulence
gene (8), now generically termed “effector genes.” Each pathogen isolate can express an
array of effectors, and the diversity of effectors across the population of any pathogen
species can be stunning (9, 10).
Unfortunately, the utility of most R alleles can be short-lived in the field, because their
deployment in monoculture selects for pathogen variants, wherein the corresponding
effector allele has suffered mutation or been lost. Effectors are virulence factors, but each
typically contributes only partially to virulence. Unrelated effectors can act redundantly by
altering the same host signaling pathway. Therefore, effector genes can often be lost without
significant impact on pathogen virulence. Likely exceptions to this principle are “core
effectors,” defined operationally by their wide distribution across the population of a
particular pathogen and their substantial contribution to pathogen virulence. Genomics-
based identification of core effectors and their utilization to functionally define new R alleles
that they activate in diverse plant germ plasm is a particularly promising strategy for
research and deployment that we discuss below.
The Plant Immune System
Research using both tractable experimental systems (Arabidopsis) and the irreplaceable
germ plasm toolkits provided by plant breeders and plant pathologists (notably in flax,
tomato, and barley) led to the isolation of the first pathogen effector genes (11) and plant R
genes (12). Additional fundamental discoveries demonstrated that plants could perceive
diverse structures generally encoded by microbes via high-affinity cell surface pattern-
recognition receptors (PRR) (13). These lines of research converged to describe a plant
immune system that consists of two interconnected tiers of receptors, one outside and one
inside the cell, that govern recognition of microbes and response to infection (14–18).
The first tier of the plant immune system is governed by extracellular surface PRRs that are
activated by recognition of evolutionarily conserved pathogen (or microbial)–associated
molecular patterns (PAMPs or MAMPs). These receptors are typically leucine-rich repeat
kinases and lysine motif (LysM) kinases (although some lack the kinase domain and thus
require a co-receptor to provide signaling function) and are broadly analogous to Toll-like
receptors in animals. Activation of PRRs leads to intracellular signaling, transcriptional
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reprogramming, and biosynthesis of a complex output response that limits microbial
colonization (13) (Fig. 1, step 1).
Successful pathogens use their effector repertoire to subvert PRR-dependent responses, to
facilitate nutrient acquisition, and to contribute to pathogen dispersal. Effector repertoires
have been described from pathogens with diverse lifestyles. These include effectors from
extracellular plant bacterial pathogens that are delivered into host cells by the type III
secretion system (TTSS) (9, 19); effectors from oomycetes and fungi (10, 20) that invaginate
specialized feeding organelles, called haustoria, into host cells; and salivary proteins
delivered to plant cells during aphid and nematode feeding (21) (Fig. 1, step 2). Effector
suites from at least two evolutionarily diverse pathogens interact with a limited set of plant
“targets,” a high proportion of which have immune system functions (Fig. 1, step 3) (22).
Most R genes encode members of an extremely polymorphic superfamily of intracellular
nucleotide-binding leucine-rich repeat (NLR) receptors, which function intracellularly and
anchor the second tier of the plant immune system (14–18). Specific NLR proteins are
activated by specific pathogen effectors. This can be via direct interaction, as receptor and
ligand, respectively (23) (Fig. 1, step 4a). Alternatively, an effector can modify its host
cellular target (or a molecular decoy of that target), and a specific NLR associated with the
target or decoy can be activated by the modification (14, 24) (Fig. 1, steps 4b and 4c). NLR
activation coordinates effector-triggered immunity, a rapid and high-amplitude reboot of
effector-suppressed, PRR-dependent outputs that limits pathogen proliferation (Fig. 1, step
5). Animal NLR proteins are likely to follow similar activation models (25).
The molecular architectures of NLR proteins in their resting, transition, and active signaling
states are poorly defined (26, 27). There are limited and conflicting data on the role of self-
association or oligomerization for sensor NLR protein function, at both pre- and
postactivation steps (28). Resting state oligomerization (in some cases), activation-
dependent intramolecular rearrangements (in essentially all cases), and activation-dependent
N-terminal signaling domain dimerization (in many but not all cases) have been
documented. Some effector-triggered responses require a pair of NLR proteins (28): One is
activated by the effector and is a “sensor NLR”; the other is required for its function and is a
“helper NLR” (27, 29). Heteromeric pairing could expand NLR repertoires (30, 31). Similar
NLR pairs can function in animal NLR systems (32, 33). Exceptions abound, and
generalizable models for NLR activation may not exist; evolution may have favored a mix
of mechanisms that were refined by coevolutionary conflict between effectors, targets or
decoys, and sensor NLRs.
The cellular site(s) of NLR activation and action are likely to be diverse. Some NLRs may
require nucleocytoplasmic shuttling for function, whereas others appear to be activated at
the plasma membrane (18, 27). These different sites of activation suggest a more
idiosyncratic model for NLR function, dictated in part by the localization of, and functional
constraints on, the effector targets whose integrity each NLR monitors.
The presence of NLRs with diverse N-terminal signaling domains in both plants and animals
suggests that this architecture confers a fundamental advantage in host defense. This
advantage may include recruitment of diverse cofactors after activation, as suggested by the
functionally relevant interaction of NLR N-terminal domains with transcription factors in
some cases (34). NLRs may facilitate tightly regulated “cooperative” threshold responses to
ligands within an evolutionarily flexible scaffold that permits innate immune systems with
limited germ line–encoded repertoires to keep pace with functionally diverse pathogen
effectors acting at a variety of intracellular sites.
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Engineering Disease Resistance in Crops: Early Successes
Successful transgenic disease resistance was demonstrated in 1986. Constitutive in planta
expression of viral coat protein gene sequences conferred virus resistance via small RNAs,
now understood to be a widely applicable mechanism for inhibiting viral replication (35).
By combining coat protein genes from three different viruses, scientists developed squash
hybrids with field-validated, multiviral resistance (Table 1). The Asgrow Seed Company
obtained regulatory approvals for transgenic commercial squash in 1994, and these continue
to be sold by Seminis today. Similar levels of resistance to this variety of viruses had not
been achieved by conventional breeding.
A similar strategy was deployed to combat papaya ringspot virus, which, by 1994,
threatened to destroy Hawaii’s papaya industry. Field trials demonstrated excellent efficacy
and high fruit quality (Table 1), and by 1998, the first transgenic virus-resistant papaya was
approved for sale in Hawaii. Disease resistance has been durable for over 15 years of
commercial use, and transgenic papaya currently accounts for ~85% of Hawaiian production
(Fig. 2). The fruit is now approved for sale in Canada and Japan.
Since the approval and commercialization of these two crops in the late 1990s, not a single
new crop with engineered disease resistance has reached the market. Research successes
exist (Table 1), and there is still potential to reduce yield losses and chemical inputs
associated with crop disease.
Effector-Targeted Strategies for Durable Disease Resistance—An Emerging
Paradigm
R gene isolation using genetics and genomics is now a reality in even the most complex
plant genomes (36, 37). Rapid and inexpensive DNA-sequencing technologies can provide
the genomes of natural field isolates of plant pathogens with impact on breeding strategies
for durable control of plant diseases (38). It is now possible to define the genomes, and thus
the effector complement, of plant pathogens isolated from infected plants in a rapid and
efficient manner. Defining core effectors facilitates identification of suites of corresponding
R genes from wild germ plasm by using transient coexpression assays, followed by either
marker-assisted breeding or transgenic deployment (Box 1). Validation of these new R genes
could be enhanced by new genome-editing methods that use transcription activator–like
effector nuclease (TALEN) (39) and clustered regulatory interspaced short palindromic
repeat (CRISPR) technologies (40, 41).
Box 1
Breeding for disease resistance
Current practices involved in breeding for disease resistance
1. Discover single R genes in wild relative species and cross into agronomic
cultivars by interspecific hybridization, followed by successive generations of
recurrent selection for resistance. This process is slow.
2. Use pathogen inoculations to test plant germ plasm for resistance without a
priori knowledge of which effector is being detected by the new R gene.
3. R gene–mediated disease resistance can be short-lived, as pathogens can mutate
to evade activating R function.
4. Interspecific hybrid breeding is sometimes difficult because of sexual
incompatibilities and/or linkage drag of undesirable traits.
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Improved practices for breeding durable resistance by genomic strategies
1. Use next-generation sequencing technologies to sequence and assemble
pathogen genomes causing disease in local fields.
2. Use computational biology to identify the most highly successful core effectors
in these strains.
3. Identify R genes that are activated by those effectors.
4. Deploy multiple, stacked R genes that recognize defined core effectors to reduce
the chance that pathogens will overcome resistance.
5. Identify and edit within the genome disease-susceptibility genes to reduce
pathogen growth and symptom development.
6. Identify and deploy antipathogenic probiotic and/or antipathogenic microbial
mixtures as seed coats.
The function of any particular R gene is likely to be durable only if the effector that activates
it is present and important for virulence in the pathogen strains that one is trying to control.
Knowledge of the effector content in local pathogen isolates can inform R gene deployment
or chemical treatment in the control of potato late blight (38). Another example is
Xanthomonas axonopodis pv. manihotis (Xam), the causal agent of cassava bacterial blight
(42). This disease devastates a staple crop in East Africa. The sequence of ~65 Xam strains
collected over a 70-year time frame, from 12 countries and three continents, revealed a core
effector set that can now serve as targets to define R genes activated by them in wild species
of Manihot and potentially other related plants in the Euphorbiaceae.
Deployment of Immune System Receptors
Research aimed at deployment of the two classes of immune receptors currently follows two
main strategies. One is to transfer PRRs that detect common microbial products into species
that lack them. For example, the Arabidopsis PRR EF-Tu receptor (EFR) recognizes the
bacterial translation elongation factor EF-Tu. Deployment of EFR into either Nicotiana
benthamiana or Solanum lycopersicum (tomato), which cannot recognize EF-Tu, conferred
resistance to a wide range of bacterial pathogens (43). The expression of EFR in tomato was
especially effective against the widespread and devastating soil bacterium Ralstonia
solanacearum. Also, the tomato PRR Verticillium 1 (Ve1) gene can be transferred from
tomato to Arabidopsis, where it confers resistance to race 1 isolates of Verticillium (44).
Identification of functional PRRs and their transfer to a recipient species that lacks an
orthologous receptor could provide a general pathway to additional examples of broadened
PRR repertoires (13).
The second strategy exploits immune responses in contexts where multiple NLR genes are
deployed simultaneously, a breeding strategy known as stacking. Such cultivars, generated
by either DNA-assisted molecular breeding or gene transfer, should provide more durable
disease resistance because pathogen evasion would require mutations in multiple effector
genes. Recent breakthroughs in DNA sequencing allow access to the huge genetic diversity
of our major crops and their relatives to functionally “mine” NLR genes directed against
different core effectors. This approach will ultimately overcome inherent barriers to
traditional crop breeding (Box 1). Illustrative examples follow.
The first “effector-rationalized” search for a potentially durable R gene was predicated on
the finding that the avrBs2 effector gene from Xanthomonas perforans, the causal agent of
bacterial spot disease of pepper and tomato, is found in most species of Xanthomonas that
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cause disease and is required for pathogen fitness (45). The Bs2 NLR gene from the wild
pepper, Capsicuum chacoense, was transformed into tomato, where it inhibited growth of
pathogen strains that contained avrBs2. Successful field trials of transgenic tomato plants
that express Bs2 demonstrated robust resistance to X. perforans without bactericidal
chemicals (46). However, rare strains of Xanthomonas have overcome Bs2-mediated
resistance in pepper by acquisition of avrBs2 mutations that avoid recognition but retain
virulence (47). Stacking of multiple R genes that each recognize a different core effector
could delay or prevent this problem.
The oomycete Phytophthora infestans causes late blight disease of potato (2). Cultivated
potato, Solanum tuberosum, is tetraploid and clonally propagated via cuttings, which
significantly hampers introgression of disease resistance from diploid wild species in the
genus Solanum. Furthermore, the pathogen is aggressive and has repeatedly adapted to
evade host resistance mediated by single R genes and chemical treatments. Most potato
cultivars are thus susceptible to P. infestans infection, which necessitates continual updating
of chemical treatments.
Genome-wide definition of effector suites across pathogen isolates collected worldwide and
of R gene distribution across Solanum sp. will have a major impact on management of
resistance to P. infestans (38). Sequencing of several P. infestans genomes has identified a
core set of effectors that can now be used to identify new sources of disease resistance
across the genus Solanum. This approach has been validated in the potato cultivar Sarpo
mira, which contains four naturally stacked R genes activated by already known P. infestans
effectors (48). Rational stacking of R genes is a general approach (49, 50) and the method of
choice for producing sustainable, durable disease resistance that will require fewer chemical
inputs.
In modern wheat and its many relatives, more than 50 different loci have been described that
confer disease resistance against wheat stem, leaf, and yellow stripe rust pathogens. A few
were known to confer resistance to the pandemic wheat rust isolate Ug99 and its derivatives,
but these were not readily incorporated into hexaploid wheat or provide only partial
resistance. The Stem rust 35 (Sr35) NLR gene was very recently cloned from a diploid
relative of cultivated wheat, Triticum monococcum, and transferred into cultivated hexaploid
wheat to derive resistance to Ug99 (36). Similarly, the Stem rust 33 (Sr33) NLR gene from
the wheat relative Aegilops tauschii was also very recently cloned and shown to encode a
wheat ortholog to the barley Mla powdery mildew–resistance genes (37). Both Sr35 and
Sr33 are fairly rare in wheat and its relatives, which accentuates the importance of diverse
germ plasm screening to identify useful new R genes. It is hoped that Sr35 and Sr33,
combined with the Sr2 gene that is known to act additively with at least Sr33 (51), could
provide durable disease resistance to Ug99 and its derivatives.
Deployment of Executor-Mediated Disease Resistance
In contrast to PRRs and NLRs, another class of plant disease resistance genes has evolved to
coopt pathogen virulence functions and open a “trap door” that stops pathogen proliferation.
Xanthomonas and Ralstonia transcription activator–like (TAL) effectors are DNA-binding
proteins delivered into plant cells, where they activate host gene expression to enhance
pathogen virulence (39). In a neat evolutionary trick, however, both the rice and pepper
lineages independently evolved TAL-effector binding sites in the promoters of genes whose
products induce hypersensitive host cell death when up-regulated and thus inhibit pathogen
proliferation. The known “executor” genes, Xa27 from rice (52) and Bs3 and Bs4c from
pepper (53, 54), encode plant proteins of unknown function that share no homology.
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Executor genes are not expressed in the absence of infection, but expression of each is
strongly induced by a specific TAL effector.
Engineered executor genes provide unique opportunities to deliver enhanced and potentially
durable disease resistance. This was demonstrated by successfully redesigning the pepper
Bs3 promoter to contain two additional binding sites for TAL effectors from disparate
pathogen strains (55). Subsequently, an engineered executor gene was deployed in rice by
adding five different TAL effector binding sites to the Xa27 promoter. The synthetic Xa27
construct was activated by TAL effectors from, and conferred resistance against, both
bacterial blight and bacterial leaf streak species of Xanthomonas (56) (Table 1).
Defining and Deploying Altered Host “Susceptibility Alleles” to Control
Plant Diseases
Most plant pathogens reprogram host plant gene expression patterns to directly benefit
pathogen fitness, as exemplified above for TAL effectors. Host genes reprogrammed by
pathogens that are required for pathogen survival and proliferation can be thought of as
“disease-susceptibility genes.” Identification and isolation of these would provide useful
sources for breeding disease resistance: their loss or alteration of function would deprive the
pathogen of a host factor required for its proliferation (57, 58). We highlight a few here.
Recessive disease-resistance genes, long known to breeders, are candidates for disease-
susceptibility genes. For example, a loss-of-function mutation in an Arabidopsis gene
encoding pectate lyase, an enzyme involved in cell wall degradation, conferred resistance to
the powdery mildew pathogen Golovinomyces (syn. Erysiphe) cichoracearum (59).
Similarly, the Barley mlo gene has been deployed against powdery mildew for more than 70
years, and it is required for pathogen invasion (60). Spontaneous mutations in pea and
tomato MLO orthologs confer resistance to powdery mildew pathogens of these plants (61,
62). And the Pseudomonas syringae bacterial effector HopZ2 targets the Arabidopsis
ortholog, MLO2, to contribute to bacterial virulence (63).
Similarly illustrative is the cloning and deployment of Lr34, a gene that provides partial
resistance to leaf and yellow rusts and powdery mildew in wheat and that has been durable
for nearly a century. Lr34 encodes an adenosine tri-phosphate (ATP)–binding cassette
(ABC) transporter. The dominant allele that provides disease resistance was recently derived
in cultivated wheat (it is not present in wild progenitors of wheat) and, like mlo, is
associated with ectopic plant cell death that may establish a “sensitized” defense state or
accelerate senescence. Transfer of the wheat Lr34 resistance allele provides broad-spectrum
resistance in barley, although with the expected cell death–lesion formation (64–66). It is
unclear whether the wheat allele that provides durable resistance is also functional for the
inferred ABC transporter activity of Lr34, and thus, the mechanism by which Lr34 confers
disease resistance remains obscure.
Naturally occurring alleles of the host translation elongation initiation factors eif4e and eif4g
double as recessive viral-resistance genes. Some have been deployed to control important
potyviruses in barley, rice, tomato, pepper, pea, lettuce, and melon (67). The discovery of
natural recessive alleles prompted a successful mutant screen for chemically induced eif4e
alleles in tomato (68).
Natural variation in the promoters of key plant-susceptibility genes can also lead to the
evolution of recessive disease-resistance alleles. For example, the recessive resistance gene
xa13 in rice is an allele of Os-8N3. Os-8N3 is transcriptionally activated by Xanthomonas
oryzae pv. oryzae strains that express the TAL effector PthXo1. The xa13 gene has a
Dangl et al. Page 7













mutated effector-binding element in its promoter that eliminates PthXo1 binding and renders
these lines resistant to strains of the pathogen that rely on PthXo1 as their essential virulence
factor. This finding also demonstrates that Os-8N3 is required for susceptibility (69).
The deployment of mutant alleles of host disease-susceptibility genes can be problematic if
the disease-susceptibility phenotype comes at the cost of altered function in other cellular
and developmental processes. This is the case for Xa13/Os-8N3, which is also required for
pollen development (70). Nevertheless, it is possible to separate disease susceptibility from
normal development. For example, mutations in the Os11N3 (OsSWEET14) TAL effector–
binding element were made by using TAL effectors fused to nucleases (TALENs). Genome-
edited rice plants with altered Os11N3 binding sites were resistant to Xanthomonas oryzae
pv. oryzae infection, but they were unaltered for the normal Os11N3 (OsSWEET14)
developmental function (71).
The identification of new susceptibility genes in crops will come from forward genetic
screens that uncover new recessive disease-resistance genes—which may, indeed, turn out to
be host-susceptibility genes—and from identification of host targets of effectors. For
example, mutant screens in Arabidopsis identified additional recessive mutations that confer
recessive resistance to the obligate biotrophs, G. cichoracearum (72) and Hyaloperonospora
arabidopsidis (73). These genes have orthologs in other plants, thus making them obvious
targets for identification of mutant alleles in crop species (Box 1).
Looking Forward: Future Challenges, Technical and Societal
In the past century of disease-resistance breeding, we were largely limited to germ plasm
from sexually compatible wild species that can recognize and resist infection, without a
priori knowledge of the effector R gene mediating the outcome (Box 1). This strategy is
slow, and field efficacy is often shortened by selection of effector gene mutants that evade
host recognition. Our current challenge is to leverage evolutionary genomic information
stored in the worldwide germ plasm diversity. The goal is to define and to stack multiple
resistance specificities active against the daunting array of economically important
pathogens, including Phytophthora, Magnaporthe, Fusarium, Pseudomonas, Ralstonia,
Xanthomonas, and gemini and potyviruses (74). At the same time, we must maintain
complex agronomic traits—such as yield, form, and flavor—and avoid yield penalties. The
precision offered by transgenic and genome editing technologies offers considerable
advantages over conventional breeding (Box 1).
Prospects for the development of durable disease resistance have improved markedly
because of the ongoing molecular dissection of the plant immune system and the advent of
ever-faster, ever-cheaper genome-sequencing technologies. Many exciting challenges are
emerging to exploit that knowledge. We can contemplate rational, stacked deployment of
multiple NLRs that each recognize a different core effector (Box 1). We will eventually be
able to engineer novel NLR recognition specificities, though this requires detailed structural
knowledge only now beginning to be unraveled (75). Combinations of stacked NLRs, new
PRRs, and genome-edited disease-susceptibility alleles that reduce or stop pathogen
proliferation are realistic possibilities. We can now monitor pathogen populations and their
effector complements in the field over space and time to inform deployment of better-suited
cultivars requiring less chemical control (38). We harbor ambitions to enhance plant
immune system function by managing defined probiotic, anti-pathogenic microbial consortia
isolated from the plant’s own microbiome (76, 77). A holistic, mechanism-based approach
will ultimately improve plant immune system function to deliver durable and sustainable
disease resistance, with minimum or no chemical input, where it is needed most in the
future.
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Among the greatest challenges remaining for deployment of next-generation disease-
resistant plants are those posed by regulatory and consumer acceptance hurdles. Virus
resistance in modified papaya and squash has been durable, and the crops have been safely
consumed for nearly 20 years, with no negative environmental impacts (78). Nevertheless,
significant anxiety remains. Sadly, commercial deployment by BASF Corporation (Badische
Anilin Soda Farbrik, AG) of a potentially valuable potato cultivar, Fortuna, containing two
stacked and potentially durable NLR genes from a wild potato species, was canceled because
of pressure from lobbies opposing genetic modification, despite the fact that it would likely
eliminate some or all of the up to 25 fungicide treatments required in Northern Europe per
year to control late blight (79). If the examples of the introduction of coffee as a beverage,
and the use of hybrid crops, such as corn, serve as guidelines, acceptance of transgenic crops
should become mainstream in about 50 to 200 years (80, 81). That timeline is simply too
long to wait to confront the issues of food security and environmental sustainability posed
by the plethora of microbes that value our crops as food sources as much as we do.
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Fig. 1. Schematic of the plant immune system
Pathogens of all lifestyle classes (color coded and labeled) express PAMPs and MAMPs as
they colonize plants (shapes are color coded to the pathogens). Plants perceive these via
extracellular PRRs and initiate PRR-mediated immunity (PTI; step 1). Pathogens deliver
virulence effectors to both the plant cell apoplast to block PAMP/MAMP perception (not
shown) and to the plant cell interior (step 2). These effectors are addressed to specific
subcellular locations where they can suppress PTI and facilitate virulence (step 3).
Intracellular NLR receptors can sense effectors in three principal ways: first, by direct
receptor ligand interaction (step 4a); second, by sensing effector-mediated alteration in a
decoy protein that structurally mimics an effector target, but has no other function in the
plant cell (step 4b); and third, by sensing effector-mediated alteration of a host virulence
target, like the cytosolic domain of a PRR (step 4c). It is not yet clear whether each of these
activation modes proceeds by the same molecular mechanism, nor is it clear how, or where,
each results in NLR-dependent effector-triggered immunity (ETI). [Modified from (17) by
Sarah R. Grant]
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Fig. 2. Hawaiian papaya plot in 2011
Hawaiian papaya plot showing diseased, devastated, non-transformed trees in the
foreground and healthy transgenic trees behind. [Photo courtesy of Dennis Gonsalves,
Agricultural Research Service, U.S. Department of Agriculture, Hawaii]
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